Cohort 1 dosing continues because they said they would keep giving the patients the does if there were no toxicity concerns. Don't read anything into it. It would be fairly rotten for them to cut terminal patients off something that MIGHT help, or might not. At least this way they have some hope.

It was always in the plan to keep dosing them so don't draw conclusions from it.